Sugambhika Pharmaceuticals Private Limited, a active private limited company, was established on 26 March 2018 in Chennai, Tamil Nadu, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24304TN2018PTC121734. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹7.50 M.
Employing 28 professional, Its leadership includes Nathamoorthy Karthik Narayan (Director), Narayanan Nathamoorthy (Director), Gayathri (Director). It holds ₹3.50 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at New. No.65B(Old No.27B), Hospital Road Saidapet,, Chennai, Tamil Nadu, 600015.
U24304TN2018PTC121734
121734
26 March 2018
₹1.00 Cr
₹7.50 M
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Sugambhika Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nathamoorthy Karthik Narayan | Director | 06 Sep 2023 | Current |
| Narayanan Nathamoorthy | Director | 28 Mar 2019 | Current |
| Gayathri | Director | 28 Mar 2019 | Current |
| Vadivelu Sakthivelan | Director | 26 Mar 2018 | Current |
| Nathamoorthy Chitra | Director | 26 Mar 2018 | Current |
| Rakshambika | Director | 06 Dec 2025 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sugambhika Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 19.7% increase. The company also saw a substantial improvement in profitability, with a 17.29% increase in profit. The company's net worth Soared by an impressive increase of 21.04%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Sugambhika Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹35,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 Feb 2019 | Others | ₹3.50 Cr | Open |
Explore comprehensive loan charge details -
Sugambhika Pharmaceuticals has a workforce of 28 employees as of Mar 26, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Sugambhika Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sugambhika Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Rakshambika was appointed as a Director was appointed as a Director on 06 Dec 2025 & has been associated with this company since 17 days . was recorded as a recent event.
Progress on Sugambhika Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Sugambhika Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai. was recorded as a recent event.
The activity Nathamoorthy Karthik Narayan was appointed as a Director was appointed as a Director on 06 Sep 2023 & has been associated with this company since 2 years 3 months . was completed.
The activity Narayanan Nathamoorthy was appointed as a Director was appointed as a Director on 28 Mar 2019 & has been associated with this company since 6 years 8 months . was completed.
Progress on Gayathri was appointed as a Director was appointed as a Director on 28 Mar 2019 & has been associated with this company since 6 years 8 months . was documented.
The CIN of Sugambhika Pharmaceuticals Private Limited is U24304TN2018PTC121734.
Sugambhika Pharmaceuticals Private Limited is headquartered at New. No.65B(Old No.27B), Hospital Road Saidapet,, Chennai, Tamil Nadu, 600015.
Sugambhika Pharmaceuticals Private Limited was incorporated on 26 March 2018.
The current directors of Sugambhika Pharmaceuticals Private Limited are
The primary industry of Sugambhika Pharmaceuticals Private Limited is Trade.
Sugambhika Pharmaceuticals Private Limited is unlisted.
The authorized capital of Sugambhika Pharmaceuticals Private Limited is ₹1.00 Cr, and the paid-up capital is ₹7.50 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX